Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice a
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The transplantation of primary hepatocytes has been shown to augment the function of damaged livers and to bridge patients to liver transplantation. However, primary hepatocytes often have low levels of engraftment and survive for only a short time after transplantation. To explore the potential benefits of using decellularized liver matrix (DLM) as a carrier for hepatocyte transplantation, DLM from whole mouse livers was generated. Human fetal hepatocytes immortalized by telomerase reconstitution (FH-hTERTs) or primary human hepatocytes were infused into the DLM, which was then implanted into the omenta of immunodeficient nonobese diabetic/severe combined immunodeficient/interleukin-2 receptor γ-deficient mice or nonobese diabetic/severe combined immunodeficient/mucopolysaccharidosis type VII mice. The removal of endogenous cellular components and the preservation of the extracellular matrix proteins and vasculature were demonstrated in the resulting DLM. Bioluminescent imaging revealed that FH-hTERTs transduced with a lentiviral vector expressing firefly luciferase survived in the DLM for 8 weeks after peritoneal implantation, whereas the luciferase signal from FH-hTERTs rapidly declined in control mice 3 to 4 weeks after transplantation via splenic injection or omental implantation after Matrigel encapsulation. Furthermore, primary human hepatocytes that were reconstituted in the DLM not only survived 6 weeks after transplantation but also maintained their function, as demonstrated by messenger RNA levels of albumin and cytochrome P450 (CYP) subtypes (CYP3A4, CYP2C9, and CYP1A1) similar to the levels in freshly isolated human primary hepatocytes (hPHs). In contrast, when hPHs were transplanted into mice via splenic injection, they failed to express CYP3A4, although they expressed albumin. In conclusion, DLM provides an excellent environment for long-term survival and maintenance of the hepatocyte phenotype after transplantation. Liver Transpl, 2011. © 2011 AASLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart
Ott, H. C., Matthiesen, T. S., Goh, S.-K., Black, L. D., Kren, S. M., Netoff, T. I., & Taylor, D. A. (2008) · Nature Medicine · doi:10.1038/nm1684 · Cited by 2,650 · cited 1×
“Recent advances in organ and tissue decellularization make it possible to obtain tissuespecific ECM from whole organs through the perfusion of the organs with various detergents.(8) In contrast to the traditional method of decellularization, in which thinly sliced tissues are immersed in various solutions for decellul…”
MethodUygun, B. E., Soto-Gutierrez, A., Yagi, H., Izamis, M.-L., Guzzardi, M. A., Shulman, C., Milwid, J., Kobayashi, N., Tilles, A., Berthiaume, F., et al. (2010) · Nature Medicine · doi:10.1038/nm.2170 · Cited by 1,370
Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering
Schmidt, C. E., & Baier, J. M. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00148-4 · Cited by 762
Assessing Porcine Liver-Derived Biomatrix for Hepatic Tissue Engineering
Lin, P., Chan, W. C. W., Badylak, S. F., & Bhatia, S. N. (2004) · Tissue Engineering · doi:10.1089/ten.2004.10.1046 · Cited by 236
Copple, B. L. (2010) · Liver International · doi:10.1111/j.1478-3231.2010.02205.x · Cited by 164
Cited by
Immunogenicity in xenogeneic scaffold generation: Antigen removal vs. decellularization
Wong, M. L., & Griffiths, L. G. (2014) · Acta Biomaterialia · doi:10.1016/j.actbio.2014.01.028 · Cited by 254
Discarded human kidneys as a source of ECM scaffold for kidney regeneration technologies
Orlando, G., Booth, C., Wang, Z., Totonelli, G., Ross, C. L., Moran, E., Salvatori, M., Maghsoudlou, P., Turmaine, M., Delario, G., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.04.033 · Cited by 194
Ren, H., Shi, X., Tao, L., Xiao, J., Han, B., Zhang, Y., Yuan, X., & Ding, Y. (2013) · Liver International · doi:10.1111/liv.12088 · Cited by 127
Park, K.-M., Hussein, K. H., Hong, S.-H., Ahn, C., Yang, S.-R., Park, S.-M., Kweon, O.-K., Kim, B.-M., & Woo, H.-M. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0313 · Cited by 113
Decellularized scaffolds in regenerative medicine
Yu, Y., Alkhawaji, A., Ding, Y., & Mei, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10945 · Cited by 113
Metadata
- Authors
- Zhou, P., Lessa, N., Estrada, D. C., Severson, E. B., Lingala, S., Zern, M. A., Nolta, J. A., & Wu, J.
- Venue
- Liver Transplantation
- Published
- 2011-04
- Volume
- 17
- Issue
- 4
- Pages
- 418-427
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2129046072
- Cited by
- 107
- References
- 5
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice a. https://app.cochat.ai/papers/10.1002/lt.22270
- The paper
- Zhou, P., Lessa, N., Estrada, D. C., Severson, E. B., Lingala, S., Zern, M. A., Nolta, J. A., & Wu, J. (2011). Decellularized liver matrix as a carrier for the transplantation of human fetal and primary hepatocytes in mice a. Liver Transplantation. https://doi.org/10.1002/lt.22270
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.